HSFX1: A Promising Drug Target / Biomarker (G100506164)

Target Name: HSFX1

NCBI ID: G100506164

HSFX1

HSFX1: A Promising Drug Target / Biomarker

High-throughput screening (HTS) experiments have revolutionized drug discovery and development, providing researchers with a rapid and efficient way to identify potential drug targets and biomarkers. One of the most promising drug targets in recent years is the protein HSFX1, which has been shown to play a crucial role in a variety of biological processes and is involved in the development and progression of various diseases, including cancer.

HSFX1: Structure and Function

HSFX1, also known as heat shock factor XI, is a protein that is expressed in a variety of tissues and cells throughout the body. It is a member of the heat shock factor (HSF) family, which includes a variety of proteins that are involved in the regulation of protein expression and stability in response to changes in temperature and other environmental factors.

The HSF family of proteins was identified in the 1970s as proteins that are able to withstand high levels of temperature and other forms of stress, such as those that occur during the production of proteins in eukaryotic cells. These proteins are able to maintain their stability and activity under these conditions because they are able to undergo a series of structural changes, known as heating or stress-induced conformational changes.

HSFX1 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, heart, brain, and cancer cells. It is highly conserved, with a calculated pI of 11.5 and a predicted localization coefficient of 0.15. HSFX1 is also known to be involved in a number of different cellular processes, including cell signaling, DNA replication, and protein stability.

One of the most significant functions of HSFX1 is its role in the regulation of DNA replication. HSFX1 has been shown to play a crucial role in the loading of the DNA template onto the eukaryotic replication machine, which is responsible for copying the genetic material of the cell to create a new daughter cell.

In addition to its role in DNA replication, HSFX1 is also involved in the regulation of cell signaling and protein stability. It has been shown to play a role in the regulation of the activity of several intracellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

HSFX1 and Cancer

The role of HSFX1 in cancer is an area of active research, and several studies have shown that it is involved in the development and progression of a variety of cancers, including breast, ovarian, and colorectal cancers.

One of the most significant findings in this regard is the involvement of HSFX1 in the development of breast cancer. Several studies have shown that HSFX1 is overexpressed in breast tissue and that this overexpression is associated with the development of breast cancer. Additionally, studies have shown that inhibiting the activity of HSFX1 has the potential to be a effective therapeutic approach for breast cancer treatment.

Another study has also shown that HSFX1 is involved in the development and progression of colorectal cancer. The results of this study suggest that HSFX1 may be a potential drug target for this disease and that inhibiting its activity may be an effective therapeutic approach.

HSFX1 as a Drug Target

The potential drug targets for HSFX1 are vast and include a number of different targets, including transcription factors, signaling pathways, and cellular processes. Some of the most promising targets for HSFX1 include the following:

1. Transcription factors: HSFX1 has been shown to play a role in the regulation of gene expression and has been shown to interact with a variety of transcription factors, including nuclear factor

Protein Name: Heat Shock Transcription Factor Family, X-linked 1

The "HSFX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSFX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets